01867oam 2200421Ia 450 991069754810332120080918161437.0(CKB)5470000002389472(OCoLC)76790551(EXLCZ)99547000000238947220061122d2006 ua 0enguran|||||||||txtrdacontentcrdamediacrrdacarrierTrends in the use and expenditures for COX-2 inhibitors and traditional nonsteroidal anti-inflammatory drugs, 1997-2003[electronic resource] /Jessica Banthin and Marc Zodet[Rockville, Md.] :Medical Expenditure Panel Survey, Agency for Healthcare Research and Quality,[2006]6 unnumbered pages digital, PDF fileStatistical brief ;#139Title from title screen (viewed Sept. 18, 2008)."September 2006."Includes bibliographical references.This Statistical Brief uses data from the Household Component of the Medical Expenditure Panel Survey (MEPS-HC) to document trends in use and expenditures for COX-2 inhibitors from 1997 to 2003 in relation to trends for traditional NSAIDS.Nonsteroidal anti-inflammatory agentsCyclooxygenase 2InhibitorsNonsteroidal anti-inflammatory agents.Cyclooxygenase 2Inhibitors.Banthin Jessica S1399465United States.Agency for Healthcare Research and Quality.Medical Expenditure Panel Survey (U.S.)VVKVVKGPOBOOK9910697548103321Trends in the use and expenditures for COX-2 inhibitors and traditional nonsteroidal anti-inflammatory drugs, 1997-20033539072UNINA